AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/183
36TH INTERNATIONAL ANNUAL-MEETING OF THE GERMAN-SOCIETY-FOR-NUCLEAR-MEDICINE
Authors: BEHR TM WORMANN B GRATZ S HOLLER E KOLB HJ HIDDEMANN W GOLDENBERG DM BECKER W
Citation: Tm. Behr et al., 36TH INTERNATIONAL ANNUAL-MEETING OF THE GERMAN-SOCIETY-FOR-NUCLEAR-MEDICINE, Nuklearmedizin, 37(2), 1998, pp. 4-101
(90)YTTRIUM-LABELED COMPLEMENTARITY-DETERMINING-REGION-GRAFTED MONOCLONAL-ANTIBODIES FOR RADIOIMMUNOTHERAPY - RADIOLABELING AND ANIMAL BIODISTRIBUTION STUDIES
Authors: GOVINDAN SV SHIH LB GOLDENBERG DM SHARKEY RM KARACAY H DONNELLY JE LOSMAN MJ HANSEN HJ GRIFFITHS GL
Citation: Sv. Govindan et al., (90)YTTRIUM-LABELED COMPLEMENTARITY-DETERMINING-REGION-GRAFTED MONOCLONAL-ANTIBODIES FOR RADIOIMMUNOTHERAPY - RADIOLABELING AND ANIMAL BIODISTRIBUTION STUDIES, Bioconjugate chemistry, 9(6), 1998, pp. 773-782
CHARACTERIZATION OF ANTIBODY MUTANTS WITH A DELETED CH2 DOMAIN AND F(AB')(2) CARRYING A HUMAN IGG(3) HINGE
Authors: LEUNG SO QU Z LOSMAN MJ WANG JR SHARKEY RM GOLDENBERG DM HANSEN HJ
Citation: So. Leung et al., CHARACTERIZATION OF ANTIBODY MUTANTS WITH A DELETED CH2 DOMAIN AND F(AB')(2) CARRYING A HUMAN IGG(3) HINGE, The FASEB journal, 12(5), 1998, pp. 5295-5295
RAPID BLOOD CLEARANCE OF MOUSE IGG2A AND HUMAN IGG1 IN MANY NUDE AND NU + MOUSE STRAINS IS DUE TO LOW IGG2A SERUM CONCENTRATIONS/
Authors: REDDY N ONG GL BEHR TM SHARKEY RM GOLDENBERG DM MATTES MJ
Citation: N. Reddy et al., RAPID BLOOD CLEARANCE OF MOUSE IGG2A AND HUMAN IGG1 IN MANY NUDE AND NU + MOUSE STRAINS IS DUE TO LOW IGG2A SERUM CONCENTRATIONS/, Cancer immunology and immunotherapy, 46(1), 1998, pp. 25-33
REDUCING THE RENAL UPTAKE OF RADIOLABELED ANTIBODY FRAGMENTS AND PEPTIDES FOR DIAGNOSIS AND THERAPY - PRESENT STATUS, FUTURE-PROSPECTS AND LIMITATIONS
Authors: BEHR TM GOLDENBERG DM BECKER W
Citation: Tm. Behr et al., REDUCING THE RENAL UPTAKE OF RADIOLABELED ANTIBODY FRAGMENTS AND PEPTIDES FOR DIAGNOSIS AND THERAPY - PRESENT STATUS, FUTURE-PROSPECTS AND LIMITATIONS, European journal of nuclear medicine, 25(2), 1998, pp. 201-212
MYELOSUPPRESSIVE CHANGES FROM SINGLE OR REPEATED DOSES OF RADIOANTIBODY THERAPY - EFFECT OF BONE-MARROW TRANSPLANTATION, CYTOKINES, AND HEMATOPOIETIC SUPPRESSION
Authors: BLUMENTHAL RD ALISAUSKAS R LEW W SHARKEY RM GOLDENBERG DM
Citation: Rd. Blumenthal et al., MYELOSUPPRESSIVE CHANGES FROM SINGLE OR REPEATED DOSES OF RADIOANTIBODY THERAPY - EFFECT OF BONE-MARROW TRANSPLANTATION, CYTOKINES, AND HEMATOPOIETIC SUPPRESSION, Experimental hematology, 26(9), 1998, pp. 859-868
INITIAL CLINICAL-EXPERIENCE WITH I-131 HUMANIZED LL2 (I-131-HLL2) ANTI-CD22 MAB AGAINST B-CELL MALIGNANCIES
Authors: JUWEID M BHATNAGAR A SHARKEY RM STADMAUER E LUGER S BURTON J STEIN R ALAVI A GOLDENBERG DM
Citation: M. Juweid et al., INITIAL CLINICAL-EXPERIENCE WITH I-131 HUMANIZED LL2 (I-131-HLL2) ANTI-CD22 MAB AGAINST B-CELL MALIGNANCIES, The Journal of nuclear medicine, 39(5), 1998, pp. 273-273
PRECLINICAL STUDIES ON YTTRIUM-90-LABELED CDR-GRAFTED MONOCLONAL-ANTIBODY FOR RADIOIMMUNOTHERAPY OF NON-HODGKINS-LYMPHOMA
Authors: GRIFFITHS GL GOVINDAN SV SHIH LB SHARKEY RM GOLDENBERG DM HANSEN HJ
Citation: Gl. Griffiths et al., PRECLINICAL STUDIES ON YTTRIUM-90-LABELED CDR-GRAFTED MONOCLONAL-ANTIBODY FOR RADIOIMMUNOTHERAPY OF NON-HODGKINS-LYMPHOMA, The Journal of nuclear medicine, 39(5), 1998, pp. 411-411
ANTIBODY FRAGMENTS IN RADIOIMMUNOTHERAPY (RIT) - THE ROLE OF THE RADIATION-DOSE AND DOSE-RATE ON TOXICITY AND ANTITUMOR EFFICACY
Authors: BEHR TM MEMTSOUDIS S SHARKEY RM BLUMENTHAL RD DUNN RM GOLDENBERG DM BECKER W
Citation: Tm. Behr et al., ANTIBODY FRAGMENTS IN RADIOIMMUNOTHERAPY (RIT) - THE ROLE OF THE RADIATION-DOSE AND DOSE-RATE ON TOXICITY AND ANTITUMOR EFFICACY, The Journal of nuclear medicine, 39(5), 1998, pp. 439-439
PATIENT-SPECIFIC (PS) ESTIMATES OF RED MARROW DOSE RESULT IN IMPROVEDCORRELATION WITH MYELOTOXICITY
Authors: DUNN RM JUWEID M SHARKEY RM GOLDENBERG DM
Citation: Rm. Dunn et al., PATIENT-SPECIFIC (PS) ESTIMATES OF RED MARROW DOSE RESULT IN IMPROVEDCORRELATION WITH MYELOTOXICITY, The Journal of nuclear medicine, 39(5), 1998, pp. 440-440
INTRAINDIVIDUAL COMPARISON OF COMPLETE IGG VERSUS FAB' FRAGMENTS OF THE ANTI-NCA-90 ANTIBODY, MN-3, FOR BONE-MARROW SCINTIGRAPHY
Authors: BEHR TM GRATZ S CONRAD M MELLER J HANSEN HJ GOLDENBERG C GOLDENBERG DM BECKER W
Citation: Tm. Behr et al., INTRAINDIVIDUAL COMPARISON OF COMPLETE IGG VERSUS FAB' FRAGMENTS OF THE ANTI-NCA-90 ANTIBODY, MN-3, FOR BONE-MARROW SCINTIGRAPHY, The Journal of nuclear medicine, 39(5), 1998, pp. 442-442
CARCINOEMBRYONIC ANTIGEN (CEA) IMAGING WITH ARCITUMOMAB DIAGNOSES PRIMARY BREAST-CANCER
Authors: NABI HA GOLDENBERG DM
Citation: Ha. Nabi et Dm. Goldenberg, CARCINOEMBRYONIC ANTIGEN (CEA) IMAGING WITH ARCITUMOMAB DIAGNOSES PRIMARY BREAST-CANCER, The Journal of nuclear medicine, 39(5), 1998, pp. 593-593
PEPTIDE-BASED RESIDUALIZING RADIOIODINE LABELS FOR RADIOIMMUNOTHERAPY
Authors: GOVINDAN SV GOLDENBERG DM STEIN R MATTES MJ SHIH LB MCBRIDE WJ HANSEN HJ GRIFFITHS GL
Citation: Sv. Govindan et al., PEPTIDE-BASED RESIDUALIZING RADIOIODINE LABELS FOR RADIOIMMUNOTHERAPY, The Journal of nuclear medicine, 39(5), 1998, pp. 989-989
ESTABLISHMENT OF A NEW B-CELL LYMPHOMA SUBCUTANEOUS TUMOR XENOGRAFT MODEL IN NONIRRADIATED NUDE-MICE
Authors: GRIFFITHS G SHIH LB SHARKEY RM GOLDENBERG DM HANSEN HJ
Citation: G. Griffiths et al., ESTABLISHMENT OF A NEW B-CELL LYMPHOMA SUBCUTANEOUS TUMOR XENOGRAFT MODEL IN NONIRRADIATED NUDE-MICE, The Journal of nuclear medicine, 39(5), 1998, pp. 1039-1039
A PRETARGETING METHOD USING STREPTAVIDIM-ANTI-CARCINOEMBRYONIC ANTIGEN AND Y-90 DOTA-PEPTIDE-BIOTIN FOR RADIOIMMUNOTHERAPY OF COLORECTAL-CANCER
Authors: SHARKEY RM KARACAY H GRIFFITHS GL ANINIPOT R ZHAO J GOLDENBERG DM
Citation: Rm. Sharkey et al., A PRETARGETING METHOD USING STREPTAVIDIM-ANTI-CARCINOEMBRYONIC ANTIGEN AND Y-90 DOTA-PEPTIDE-BIOTIN FOR RADIOIMMUNOTHERAPY OF COLORECTAL-CANCER, The Journal of nuclear medicine, 39(5), 1998, pp. 1078-1078
PRECLINICAL MULTIMODAL THERAPY OF 3 HUMAN COLONIC-CANCER XENOGRAFTS USING RADIOIMMUNOTHERAPY (RAIT) AND CHEMOTHERAPY
Authors: BLUMENTHAL RD LEW W REISING A MODRAK D OSORIO L GOLD DV YING X GOLDENBERG DM
Citation: Rd. Blumenthal et al., PRECLINICAL MULTIMODAL THERAPY OF 3 HUMAN COLONIC-CANCER XENOGRAFTS USING RADIOIMMUNOTHERAPY (RAIT) AND CHEMOTHERAPY, The Journal of nuclear medicine, 39(5), 1998, pp. 1088-1088
PHARMACOKINETICS, DOSIMETRY AND TOXICITY OF RHENIUM-188-LABELED ANTICARCINOEMBRYONIC ANTIGEN MONOCLONAL-ANTIBODY, MN-14, IN GASTROINTESTINAL CANCER
Authors: JUWEID M SHARKEY RM SWAYNE LC GRIFFITHS GL DUNN R GOLDENBERG DM
Citation: M. Juweid et al., PHARMACOKINETICS, DOSIMETRY AND TOXICITY OF RHENIUM-188-LABELED ANTICARCINOEMBRYONIC ANTIGEN MONOCLONAL-ANTIBODY, MN-14, IN GASTROINTESTINAL CANCER, The Journal of nuclear medicine, 39(1), 1998, pp. 34-42
INTRACELLULAR PROCESSING OF TC-99(M)-ANTIBODY CONJUGATES
Authors: KARACAY H ONG GL HANSEN HJ GRIFFITHS GL GOLDENBERG DM MATTES MJ
Citation: H. Karacay et al., INTRACELLULAR PROCESSING OF TC-99(M)-ANTIBODY CONJUGATES, Nuclear medicine communications, 19(10), 1998, pp. 971-979
CARBOHYDRATES ENGINEERED AT ANTIBODY CONSTANT DOMAINS CAN BE USED FORSITE-SPECIFIC CONJUGATION OF DRUGS AND CHELATES
Authors: QU ZX SHARKEY RM HANSEN HJ SHIH LB GOVINDAN SV SHEN J GOLDENBERG DM LEUNG SO
Citation: Zx. Qu et al., CARBOHYDRATES ENGINEERED AT ANTIBODY CONSTANT DOMAINS CAN BE USED FORSITE-SPECIFIC CONJUGATION OF DRUGS AND CHELATES, Journal of immunological methods, 213(2), 1998, pp. 131-144
EXPERIMENTAL STUDIES ON THE ROLE OF ANTIBODY FRAGMENTS IN CANCER RADIO-IMMUNOTHERAPY - INFLUENCE OF RADIATION-DOSE AND DOSE-RATE ON TOXICITY AND ANTITUMOR EFFICACY
Authors: BEHR TM MEMTSOUDIS S SHARKEY RM BLUMENTHAL RD DUNN RM GRATZ S WIELAND E NEBENDAHL K SCHMIDBERGER H GOLDENBERG DM BECKER W
Citation: Tm. Behr et al., EXPERIMENTAL STUDIES ON THE ROLE OF ANTIBODY FRAGMENTS IN CANCER RADIO-IMMUNOTHERAPY - INFLUENCE OF RADIATION-DOSE AND DOSE-RATE ON TOXICITY AND ANTITUMOR EFFICACY, International journal of cancer, 77(5), 1998, pp. 787-795
THERAPEUTIC EFFICACY AND DOSE-LIMITING TOXICITY OF AUGER-ELECTRON VS.BETA-EMITTER IN RADIOIMMUNOTHERAPY WITH INTERNALIZING ANTIBODIES - EVALUATION OF I-125-LABELED VS I-131-LABELED CO17-1A IN A HUMAN COLORECTAL-CANCER MODEL
Authors: BEHR TM SGOUROS G VOUGIOUKAS V MEMTSOUDIS S GRATZ S SCHMIDBERGER H BLUMENTHAL RD GOLDENBERG DM BECKER W
Citation: Tm. Behr et al., THERAPEUTIC EFFICACY AND DOSE-LIMITING TOXICITY OF AUGER-ELECTRON VS.BETA-EMITTER IN RADIOIMMUNOTHERAPY WITH INTERNALIZING ANTIBODIES - EVALUATION OF I-125-LABELED VS I-131-LABELED CO17-1A IN A HUMAN COLORECTAL-CANCER MODEL, International journal of cancer, 76(5), 1998, pp. 738-748
TYROSINE, PHENYLALANINE AND DISULFIDE CONTRIBUTIONS TO THE CIRCULAR-DICHROISM OF PROTEINS - CD SPECTRA OF WILD-TYPE AND MUTANT BPTI
Authors: SREERAMA N POWERS ME MANNING MC GOLDENBERG DM WOODY RW
Citation: N. Sreerama et al., TYROSINE, PHENYLALANINE AND DISULFIDE CONTRIBUTIONS TO THE CIRCULAR-DICHROISM OF PROTEINS - CD SPECTRA OF WILD-TYPE AND MUTANT BPTI, Biophysical journal, 74(2), 1998, pp. 63-63
CLINICAL RELEVANCE OF IMMUNOSCINTIGRAPHY WITH TC-99M-LABELED ANTI-CEAANTIGEN-BINDING FRAGMENTS IN THE FOLLOW-UP OF PATIENTS WITH COLORECTAL-CARCINOMA - ASSESSMENT OF RESECTABILITY BY A COMBINATION OF CONVENTIONAL IMAGING METHODS
Authors: BEHR TM BECKER W GOLDENBERG DM SCHEELE JR WOLF FG
Citation: Tm. Behr et al., CLINICAL RELEVANCE OF IMMUNOSCINTIGRAPHY WITH TC-99M-LABELED ANTI-CEAANTIGEN-BINDING FRAGMENTS IN THE FOLLOW-UP OF PATIENTS WITH COLORECTAL-CARCINOMA - ASSESSMENT OF RESECTABILITY BY A COMBINATION OF CONVENTIONAL IMAGING METHODS, Deutsche Medizinische Wochenschrift, 122(15), 1997, pp. 463-470
DEVELOPMENT OF A STREPTAVIDIN-ANTI-CARCINOEMBRYONIC ANTIGEN-ANTIBODY,RADIOLABELED BIOTIN PRETARGETING METHOD FOR RADIOIMMUNOTHERAPY OF COLORECTAL-CANCER - REAGENT DEVELOPMENT
Authors: KARACAY H SHARKEY RM GOVINDAN SV MCBRIDE WJ GOLDENBERG DM HANSEN HJ GRIFFITHS GL
Citation: H. Karacay et al., DEVELOPMENT OF A STREPTAVIDIN-ANTI-CARCINOEMBRYONIC ANTIGEN-ANTIBODY,RADIOLABELED BIOTIN PRETARGETING METHOD FOR RADIOIMMUNOTHERAPY OF COLORECTAL-CANCER - REAGENT DEVELOPMENT, Bioconjugate chemistry, 8(4), 1997, pp. 585-594
DEVELOPMENT OF A STREPTAVIDIN-ANTI-CARCINOEMBRYONIC ANTIGEN-ANTIBODY,RADIOLABELED BIOTIN PRETARGETING METHOD FOR RADIOIMMUNOTHERAPY OF COLORECTAL-CANCER - STUDIES IN A HUMAN COLON-CANCER XENOGRAFT MODEL
Authors: SHARKEY RM KARACAY H GRIFFITHS GL BEHR TM BLUMENTHAL RD MATTES MJ HANSEN HJ GOLDENBERG DM
Citation: Rm. Sharkey et al., DEVELOPMENT OF A STREPTAVIDIN-ANTI-CARCINOEMBRYONIC ANTIGEN-ANTIBODY,RADIOLABELED BIOTIN PRETARGETING METHOD FOR RADIOIMMUNOTHERAPY OF COLORECTAL-CANCER - STUDIES IN A HUMAN COLON-CANCER XENOGRAFT MODEL, Bioconjugate chemistry, 8(4), 1997, pp. 595-604
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>